E25: Jeff Galvin, CEO of Addimmune on Finding a Cure for HIV
Jeff Galvin, CEO of Addimmune, sits down with David Weisburd to discuss cell and gene therapy, and how Addimmune is working on a functional solution for HIV. We’re proudly sponsored by Bidav Insurance Group, visit lux-str.com if you’re ready to level up your insurance plans. (0:00) Episode Preview (2:21) Jeff’s…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from How I Invest with David Weisburd
See all episodes →
E433: AlphaSense’s Chris Ackerson on AI, the Future of Finance & Finding Alpha
E432: $24 Billion Investor on Private Credit, the Psychology of Winning & Fear of Failure
E431: Marty Kausas on AI, Trillion Dollar Startups & Founder Psychology
Similar episodes from other shows
More like How I Invest with David Weisburd →
EP 32: AI Discovers Drugs: The 2026 Clinical Trial Moment for AI in Biotech
Optovolution: Teaching Proteins to Think Like Computers (EP. 31)
58%Why The Key to Treating Cancer May Be In Your Gut, with Thomas Gajewski
EP 29: AlphaFold, AlphaGenome, And the Scientific Revolution
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.